These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22383704)

  • 1. Bcl-x inactivation in macrophages accelerates progression of advanced atherosclerotic lesions in Apoe(-/-) mice.
    Shearn AI; Deswaerte V; Gautier EL; Saint-Charles F; Pirault J; Bouchareychas L; Rucker EB; Beliard S; Chapman J; Jessup W; Huby T; Lesnik P
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1142-9. PubMed ID: 22383704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.
    Gautier EL; Huby T; Witztum JL; Ouzilleau B; Miller ER; Saint-Charles F; Aucouturier P; Chapman MJ; Lesnik P
    Circulation; 2009 Apr; 119(13):1795-804. PubMed ID: 19307478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques.
    Tsukano H; Gotoh T; Endo M; Miyata K; Tazume H; Kadomatsu T; Yano M; Iwawaki T; Kohno K; Araki K; Mizuta H; Oike Y
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1925-32. PubMed ID: 20651282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
    Thorp E; Kuriakose G; Shah YM; Gonzalez FJ; Tabas I
    Circulation; 2007 Nov; 116(19):2182-90. PubMed ID: 17967777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice.
    Boesten LS; Zadelaar AS; van Nieuwkoop A; Hu L; Jonkers J; van de Water B; Gijbels MJ; van der Made I; de Winther MP; Havekes LM; van Vlijmen BJ
    FASEB J; 2006 May; 20(7):953-5. PubMed ID: 16585057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice.
    Moura R; Tjwa M; Vandervoort P; Van Kerckhoven S; Holvoet P; Hoylaerts MF
    Circ Res; 2008 Nov; 103(10):1181-9. PubMed ID: 18818405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis.
    Yamada S; Ding Y; Tanimoto A; Wang KY; Guo X; Li Z; Tasaki T; Nabesima A; Murata Y; Shimajiri S; Kohno K; Ichijo H; Sasaguri Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1555-64. PubMed ID: 21527753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
    Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice.
    Boesten LS; Zadelaar AS; van Nieuwkoop A; Hu L; Teunisse AF; Jochemsen AG; Evers B; van de Water B; Gijbels MJ; van Vlijmen BJ; Havekes LM; de Winther MP
    Atherosclerosis; 2009 Dec; 207(2):399-404. PubMed ID: 19608184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2.
    Thorp E; Li Y; Bao L; Yao PM; Kuriakose G; Rong J; Fisher EA; Tabas I
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):169-72. PubMed ID: 18988889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
    Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
    Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions.
    Dickhout JG; Lhoták Š; Hilditch BA; Basseri S; Colgan SM; Lynn EG; Carlisle RE; Zhou J; Sood SK; Ingram AJ; Austin RC
    FASEB J; 2011 Feb; 25(2):576-89. PubMed ID: 20966213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhou J; Lhoták S; Hilditch BA; Austin RC
    Circulation; 2005 Apr; 111(14):1814-21. PubMed ID: 15809369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting macrophage survival delays progression of pre-existing atherosclerotic lesions through macrophage-derived apoE.
    Bouchareychas L; Pirault J; Saint-Charles F; Deswaerte V; Le Roy T; Jessup W; Giral P; Le Goff W; Huby T; Gautier EL; Lesnik P
    Cardiovasc Res; 2015 Oct; 108(1):111-23. PubMed ID: 26092098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.